OOIR: Observatory of International Research

Papers

(The H4-Index of Rheumatology is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Granulomatosis with polyangiitis presenting as obstructive uropathy and vasculitic myopathy	203
Comment on: Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis	96
Comment on: Increased risk of osteoporosis and femoral neck fractures in patients with familial Mediterranean fever—a large retrospective cohort study	89
Comment on: AI am a rheumatologist: a practical primer to large language models for rheumatologists: reply	88
Boxer’s shape, an unusual finding in nailfold capillaroscopy	81
Correction to: Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis	71
Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply	71
Prosthetic infections following tocilizumab treatment in patients with rheumatoid arthritis	69
Comment on: Predictors of lack of response to methotrexate in juvenile idiopathic arthritis–associated uveitis	68
E44 Differences of hematological abnormalities between COVID-19 infection and multisystemic inflammatory syndrome (MIS-C)	66
P011 Rituximab and COVID-19 vaccines; are they fit for purpose?	64
P042 Using a Genetic PROBability tool (G-PROB) to aid diagnosis of patients with inflammatory arthritis: results from the Norfolk Arthritis Register	63
29 Juvenile idiopathic arthritis and osteogenesis imperfecta: an exceptional association	60
67 Double impact: hypophosphatemic rickets and vitamin D intoxication	59
P114 Medication adherence to b/tsDMARDS remains sub-optimal in refractory rheumatoid arthritis	57
P173 The positive utility of PSAID-12 score in remote monitoring and the impact of gender and treatment on patient reported outcomes in psoriatic arthritis	55
E046 Lytic lesions; metastatic disease or gout?	54
P058 Pneumocystis Jirovecii Infection in autoimmune inflammatory rheumatic diseases in Oxford	53
P073 Functional investigation of Osteoarthritis-associated non-coding variants using CRISPR/Cas9-mediated perturbation of active enhancer regions	53
P107 Long-term efficacy of baricitinib in patients with rheumatoid arthritis with inadequate response to bDMARDs: results from RA-BEYOND up to 6.9-years of treatment	52
E051 Audit of the management of patients over 75 with osteoporotic fragility fractures in primary care	51
P041 Successful reversal of microvascular damage with standard therapy in a case of dermatomyositis overlap syndrome	51
P043 Income-Related Health Inequality and Osteoarthritis Intervention Outcomes: a Cohort Study	50
P110 Challenges of meeting NICE guidance for rheumatoid arthritis in the modern era: a service audit	48
E078 Inflammation modifies the effect of rheumatoid arthritis in overall mortality among females	47

26 Kawasaki’s disease vs systemic juvenile idiopathic arthritis, a diagnostic dilemma	47
P004 Empowering the reproductive choices of patients with rheumatic disease: using the BSR 2022 pregnancy guidelines audit tool to evaluate pre-conception medication advice	46
Comment on: Associations between loneliness, disease activity, and disease impact in inflammatory arthritis: a nationwide cross-sectional study among more than 12 000 patients	45
P133 Experiences of people with digital ulcers through filmed interviews	44
P004 Temporal and regional variation in the initiation of biologic and targeted synthetic DMARDs for rheumatoid arthritis: a nationwide cohort study	44
OA12 An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years	44
P174 Identifying patterns of fatigue across flares in patients with axial spondyloarthritis	43
P193 Bimekizumab improves key symptoms, disease activity and function in patients across the full spectrum of axial spondyloarthritis up to week 24: results from two phase 3 studies	43
P104 The role of occupational therapy for the self-management of rheumatoid arthritis: a mixed methods systematic review	42
54 Kawasaki disease: experience in a general paediatric department of the CHU de Annaba Algeria	42
OA22 Methotrexate drug monitoring and referral patterns to Hepatology - can we improve detection and monitoring of hepatoxicity with methotrexate use?	41
Bezoar secondary to NSAID use in a patient with inflammatory arthritis	40
A case of carpal tunnel syndrome caused by gouty tophi confirmed by dual-source CT	39
Bullous periorbital oedema in anti-p155/140-positive dermatomyositis: a case series	39
Giant cell arteritis of the prostate	39
The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership	39